Martina Smolic

Citirano

	Sve	Od 2018.
Citati	1256	1066
H-indeks	18	16
i10-indeks	26	19

320

160

240

20082009201020112012201320142015201620172018201920202021202220238 12 19 15 14 15 11 22 17 43 31 75 126 245 302 277

Javni pristup

Prikaži sve

4 članka

0 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Robert SmolicAssociate Professor, Josip Juraj Strossmayer University of Osijek, Faculty of Dental Medicine andPotvrđena adresa e-pošte na fdmz.hr
Lucija KunaDepartment of pharmacology and biochemistry, Faculty of dental medicine and health OsijekPotvrđena adresa e-pošte na fdmz.hr
Aleksandar VcevFull Professor with Tenure, Faculty of Dental Medicine and Health Osijek, University of OsijekPotvrđena adresa e-pošte na fdmz.hr
Tomislav KizivatFaculty of Medicine Osijek, Clinical Hospital OsijekPotvrđena adresa e-pošte na kbco.hr
Ines Bilic-ĆurčićIzv. prof . na Katedri za farmakologiju, Sveučilište J.J.StrossmayerPotvrđena adresa e-pošte na mefos.hr
Kristina BojanicRadiologist, Ultrasound subspecialist, Assoc.Prof. Faculty of Dental Medicine and HelthPotvrđena adresa e-pošte na dzo.hr
Hrvoje RoguljićCardiology Fellow; Postdoctoral Fellow/Teaching Assistant of PharmacologyPotvrđena adresa e-pošte na mefos.hr
Kristina Kralikdr. sc., predavač, Medicinski fakultet Osijek, Sveučilište Josipa Jurja Strossmayera u OsijekuPotvrđena adresa e-pošte na mefos.hr
Antun TucakProfessor emeritus, dr.med. Medicinski fakultet Osijek, Sveučilište Josipa Jurja Strossmayera u Osijeku, dopisni član HAZUPotvrđena adresa e-pošte na mefos.hr
Gordana Ivanacizv.prof.dr.sc, Medicinski fakultet Sveučilišta u ZagrebuPotvrđena adresa e-pošte na kbd.hr
Sonja VukadinTeaching and Research Assistant, Faculty of Dental Medicine and Health and Faculty of MedicinePotvrđena adresa e-pošte na fdmz.hr
Ana PetrovicFaculty of Dental Medicine and Health Osijek. Faculty of Medicine Osijek.Potvrđena adresa e-pošte na fdmz.hr
Vjera NinčevićAsistent u Katedri za farmakologiju, Medicinski fakultet OsijekPotvrđena adresa e-pošte na mefos.hr
Tea Omanovic KolaricAsistent u Katedri za farmakologiju i biokemiju, Fakultet za dentalnu medicinu i zdravstvo; AsistentPotvrđena adresa e-pošte na mefos.hr
Marko DuvnjakUniversity hospital Sestre milosrdnicePotvrđena adresa e-pošte na kbcsm.hr
Maja Cigrovski Berkovicendokrinolog i dijabetolog, Kineziološki fakultet Sveučilišta u ZagrebuPotvrđena adresa e-pošte na kif.hr
Lucija Virović JukićUniversity of Zagreb School of Medicine, Sestre milosrdnice University Hospital, Zagreb, CroatiaPotvrđena adresa e-pošte na kbcsm.hr
Miroslav SikoraPostdoktorand, Fakultet za dentalnu medicinu i zdravstvo, Sveučilište J.J. Strossmayera u OsijekuPotvrđena adresa e-pošte na fdmz.hr
Hrvoje MihaljUniversity Hospital OsijekPotvrđena adresa e-pošte na kbco.hr
Vatroslav Šerićizv.prof.dr.sc., Sveučilište J.J. Strossmayer OsijekPotvrđena adresa e-pošte na kbo.hr

Prati

Martina Smolic

Professor, University of Osijek, Faculty of Dental Medicine and Health, Faculty of Medicine

Potvrđena adresa e-pošte na mefos.hr

Pharmacology HCV treatment Drug toxicity


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options L Kuna, J Jakab, R Smolic, N Raguz-Lucic, A Vcev, M Smolic Journal of clinical medicine 8 (2), 179, 2019	268	2019
Models of drug induced liver injury (DILI)–current issues and future perspectives L Kuna, I Bozic, T Kizivat, K Bojanic, M Mrso, E Kralj, R Smolic, GY Wu, ... Current drug metabolism 19 (10), 830-838, 2018	114	2018
Hepatitis C virus, insulin resistance, and steatosis D Kralj, LV Jukić, S Stojsavljević, M Duvnjak, M Smolić, IB Čurčić Journal of clinical and translational hepatology 4 (1), 66, 2016	111	2016
HCV extrahepatic manifestations L Kuna, J Jakab, R Smolic, GY Wu, M Smolic Journal of Clinical and Translational Hepatology 7 (2), 172, 2019	79	2019
Renal benefits of SGLT 2 inhibitors and GLP-1 receptor agonists: evidence supporting a paradigm shift in the medical management of type 2 diabetes V Ninčević, T Omanović Kolarić, H Roguljić, T Kizivat, M Smolić, ... International Journal of Molecular Sciences 20 (23), 5831, 2019	65	2019
Psoriasis severity—a risk factor of insulin resistance independent of metabolic syndrome MV Polic, M Miskulin, M Smolic, K Kralik, I Miskulin, MC Berkovic, ... International Journal of Environmental Research and Public Health 15 (7), 1486, 2018	42	2018
Implementation of Elastography Score and Strain Ratio in Combination with B-Mode Ultrasound Avoids Unnecessary Biopsies of Breast Lesions GI Kristina Bojanic'Correspondence informationKristina Bojanic , Natasa ... Ultrasound in Medicine and Biology (UMB) 43 (4), 804-816, 2017	41*	2017
Comprehensive review of knee osteoarthritis pharmacological treatment and the latest professional societies’ guidelines D Primorac, V Molnar, V Matišić, D Hudetz, Ž Jeleč, E Rod, F Čukelj, ... Pharmaceuticals 14 (3), 205, 2021	37	2021
Antioxidant pre-treatment reduces the toxic effects of oxalate on renal epithelial cells in a cell culture model of urolithiasis T Kizivat, M Smolić, I Marić, M Tolušić Levak, R Smolić, I Bilić Čurčić, ... International journal of environmental research and public health 14 (1), 109, 2017	35	2017
Prevalence of metabolic syndrome in the interior of Croatia: the Baranja region S Tucak-Zorić, I Bilić Čurčić, H Mihalj, I Dumančić, Ž Zelić, ... Collegium antropologicum 32 (3), 659-665, 2008	35	2008
Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients O Polašek, G Gunjača, I Kolčić, L Zgaga, S Džijan, R Smolić, M Smolić, ... Croatian medical journal 51 (1), 48-53, 2010	31	2010
Hypothyroidism and nonalcoholic fatty liver disease: pathophysiological associations and therapeutic implications T Kizivat, I Maric, D Mudri, IB Curcic, D Primorac, M Smolic Journal of clinical and translational hepatology 8 (3), 347, 2020	22	2020
Molecular mechanisms of resistance to immune checkpoint inhibitors in melanoma treatment: an update S Vukadin, F Khaznadar, T Kizivat, A Vcev, M Smolic Biomedicines 9 (7), 835, 2021	21	2021
Mechanisms of hepatic cholestatic drug injury TO Kolarić, V Ninčević, R Smolić, M Smolić, GY Wu Journal of Clinical and Translational Hepatology 7 (1), 86, 2019	21	2019
Targeting the Wnt signaling pathway in liver fibrosis for drug options: an update K Duspara, K Bojanic, JI Pejic, L Kuna, TO Kolaric, V Nincevic, R Smolic, ... Journal of Clinical and Translational Hepatology 9 (6), 960, 2021	20	2021
Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update H Roguljic, V Nincevic, K Bojanic, L Kuna, R Smolic, A Vcev, D Primorac, ... Frontiers in Pharmacology 12, 678546, 2021	19	2021
Potential role of RNAi in the treatment of HCV infection M Volarevic, R Smolic, CH Wu, GY Wu Expert Review of Anti-infective Therapy 5 (5), 823-831, 2007	19	2007
Obesity paradox in chronic liver diseases: product of bias or a real thing? IB Curcic, MC Berkovic, L Kuna, H Roguljic, R Smolic, SC Varzic, LV Jukic, ... Journal of clinical and translational hepatology 7 (3), 275, 2019	18	2019
Biochemical bone turnover markers: significance in patients with osteoporosis I Mihaljević, D Mudri, R Smolić, M Smolić, S Tucak-Zorić Collegium antropologicum 33 (2), 21-24, 2009	17	2009
Drug-induced fatty liver disease: Pathogenesis and treatment TO Kolaric, V Nincevic, L Kuna, K Duspara, K Bojanic, S Vukadin, ... Journal of Clinical and Translational Hepatology 9 (5), 731, 2021	16	2021

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori